Skip to main content
Veterinary Medicines

LINCOLAB 400 mg/g POLVO PARA ADMINISTRACION EN AGUA DE BEBIDA

Authorised
  • Lincomycin hydrochloride

Product identification

Medicine name:
LINCOLAB 400 mg/g POLVO PARA ADMINISTRACION EN AGUA DE BEBIDA
Active substance:
  • Lincomycin hydrochloride
Target species:
  • Pig
  • Chicken (broiler)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    400.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        1
        day
    • Chicken (broiler)
      • Meat and offal
        5
        day
      • Eggs
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Karizoo S.A.
  • Labiana Life Sciences S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 1954 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."